New RA drug candidate SOL-116 enters first human safety tests
NCT ID NCT05576012
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This early-stage study tested a new drug called SOL-116 in 56 healthy volunteers and people with rheumatoid arthritis. The main goal was to check if the drug is safe and how the body processes it. This is a first step to see if SOL-116 could help control rheumatoid arthritis in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHDR (Stichting Centre for Human Drug Research)
Leiden, Netherlands
-
QPS Netherlands B.V.
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.